The GENDER ATTENTION Observational Study: Gender and Hormonal Status Differences in the Incidence of Adverse Events During Cyclosporine Treatment in Psoriatic Patients
暂无分享,去创建一个
E. Berardesca | S. Chimenti | K. Peris | G. Vena | S. Calvieri | G. Lembo | G. Banfi | F. Ayala | G. Girolomoni | A. Zullo | A. Ori | C. De Simone | G. Micali | M. L. Flori | G. Stinco | A. Parodi | S. Cannavò | N. Cassano | L. Simoni | O. De Pità | A. Graziottin | G. Borroni | F. Cusano | M. Congedo | S. Piaserico | D. Colombo | C. Potenza | A. Locatelli | M. Bernengo | E. Zagni | M. Papini | M. Marconi | A. Lanzoni | R. Filotico | L. Stingeni | C. Magnoni | G. Ricotti | A. Motolese | S. di Nuzzo | G. Albertini | A. Cattaneo | A. Piccirillo | G. Bellia | M. Pau | F. Kokelj | E. Colombo | P. C. Pinton | N. Lanci | L. Zichichi | S. Amato | G. Valenti | M. Germino | D. Donadio | R. Ceschini | Christian Amici | P. Sedona | G. Fiori | C. Fornasa | M. Bongiorno | F. Bardazzi | C. Longagnani | Salvatore Fabio Ferderico Maria Grazia Maria Rita Giovanni S Amato Ayala Bardazzi Bernengo Bongiorno | C. Cannarozzo | S. Donelli | S. Sala | Francesca Trevisan | G. Magri | Saide Sala
[1] D. Colombo,et al. Cyclosporine and Herbal Supplement Interactions , 2014, Journal of toxicology.
[2] Rosa Parisi,et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. , 2013, The Journal of investigative dermatology.
[3] S. Klein,et al. Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[4] I. Spoletini,et al. A GENS-based approach to cardiovascular pharmacology: impact on metabolism, pharmacokinetics and pharmacodynamics. , 2011, Therapeutic delivery.
[5] A. Francavilla,et al. Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. , 2011, Gastroenterology.
[6] R. Alaghehbandan,et al. Adverse Drug Events in Adult Patients Leading to Emergency Department Visits , 2010, The Annals of pharmacotherapy.
[7] E. Olshansky,et al. Women's mental health: depression and anxiety. , 2009, The Nursing clinics of North America.
[8] Josip Car,et al. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005 , 2007, BMC clinical pharmacology.
[9] V. Cuomo,et al. Gender differences in drug responses. , 2007, Pharmacological research.
[10] A. Holdcroft,et al. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females? , 2006, Pharmacoepidemiology and drug safety.
[11] I. Heineck,et al. Adverse drug reactions: a cohort study in internal medicine units at a university hospital , 2006, European Journal of Clinical Pharmacology.
[12] G. Trifirò,et al. Adverse drug events in emergency department population: a prospective Italian study , 2005, Pharmacoepidemiology and drug safety.
[13] M. Anthony. Male/female differences in pharmacology: safety issues with QT-prolonging drugs. , 2005, Journal of women's health.
[14] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[15] M. Atkinson,et al. Health and Quality of Life Outcomes , 2004 .
[16] M. Cesari,et al. Adverse Drug Reactions as Cause of Hospital Admissions: Results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA) , 2002, Journal of the American Geriatrics Society.
[17] A. W. Lenderink,et al. Risk factors for the development of adverse drug events in hospitalized patients , 2000, Pharmacy World and Science.
[18] F. Follath,et al. Epidemiology of drug exposure and adverse drug reactions in two swiss departments of internal medicine. , 2000, British journal of clinical pharmacology.
[19] R. Mann,et al. Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. , 1998, British journal of clinical pharmacology.
[20] S. Knowles,et al. Gender Differences in Adverse Drug Reactions , 1998, Journal of clinical pharmacology.
[21] A. Kashuba,et al. Physiological Changes During the Menstrual Cycle and Their Effects on the Pharmacokinetics and Pharmacodynamics of Drugs , 1998, Clinical pharmacokinetics.
[22] S. Chimenti,et al. Therapeutic approaches in psoriasis: a post-hoc analysis of the PSYCHAE study from a gender point of view , 2014 .
[23] F. Franconi,et al. Sex and gender in adverse drug events, addiction, and placebo. , 2012, Handbook of experimental pharmacology.
[24] C. Pedone,et al. Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population. , 2005, Archives of gerontology and geriatrics.
[25] C. Naranjo,et al. Sex-related variations in the frequency and characteristics of adverse drug reactions. , 1980, International journal of clinical pharmacology, therapy, and toxicology.